Refine Results
- Content Type
-
Content Type
- Analysis Platform
-
Product
- Language
-
Language
Recently updated Cancer Immunotherapy Handbook featuring the latest high impact xCELLigence publications and newly released supporting information.
- Publication Part Number: 5994-1303EN
- Created: 08 July 2025
- 6 MB
Describes use of a tethering approach to immobilize liquid tumor cell lines on to the surface of gold biosensors embedded in an Agilent E-Plate.
- Publication Part Number: 5994-1066EN
- Created: 27 June 2025
- 687 KB
This document is an information guide and checklist prepared for you that outlines the supplies, space, and utility requirements for the system set up in your lab.
- Publication Part Number: 300600890
- Created: 01 Apr 2025
- 537 KB
In this application note, Antibody Analytics (Motherwell, UK) integrates IndEx-2, an advanced in vitro cell-based platform engineered to modulate the expression of one or two target antigens across a range of biologically relevant levels, with the...
- Publication Part Number: 5994-7175EN
- Created: 06 June 2024
- 2 MB
This poster aims to demonstrate the capability of impedancebased xCELLigence RTCA assays for virus and antibody titer, as well as for identification and characterization of antiviral drugs.
- Created: 25 Apr 2025
- 930 KB
This study aims to optimize and validate a drug safety testing workflow that integrates mitochondrial toxicity assessment using Seahorse XF analysis solution with cell viability assessment via the xCELLigence RTCA platform.
- Created: 19 Mar 2025
- 437 KB
There is a need for functional potency assays that can be used to rapidly test the efficacy of different immunotherapy approaches, including but not limited tosmall molecules, biologics, cell therapies, or combinations of these agents
- Publication Part Number: #91
- Created: 19 Mar 2025
- 2 MB
This quick reference guide provides detailed instructions on how to prepare, perform, and evaluate the impedance-based TCID50 protocol using the xCELLigence RTCA Software Pro Virology module to determine viral titer
- Publication Part Number: 5994-7860EN
- Created: 18 Mar 2025
- 143 KB
This editorial showcases Agilent solutions for metabolic modulation enhancing CAR T-cell activation, persistence, and serial killing for improved cancer immunotherapy
- Publication Part Number: 5994-7739EN
- Created: 04 Nov 2024
- 830 KB
SPS 2024. Poster 112-D. To explore the potential on/off target immune-mediated toxicity of EpCAM-CD3 BiTE antibodies, a panel of human primary cells representing different tissues was exposed to EpCAM BiTE in the presence of PBMCs and monitored in...
- Publication Part Number: SPS112D
- Created: 23 Sep 2024
- 793 KB
This editorial will discuss the potency assays available for cellular immunotherapies, the regulatory criteria they must meet, and the challenges faced in measuring immune cell cytotoxicity.
- Publication Part Number: 5994-7162EN
- Created: 15 Feb 2024
- 1 MB
This quick reference guide describes the setup of experiments on the xCELLigence RTCA MP (00380601040) system using RTCA Software PRO (v2.0 and newer).
- Publication Part Number: 5994-4900
- Created: 08 Feb 2024
- 366 KB